ichorbio

The Bench Brief

Science EN ↓ Epizody: 2

Welcome to The Bench Brief, presented by ichorbio. This is the essential channel for life science researchers, PIs, investors, and industry professionals focused on immuno-oncology, antibody development, cell therapy, and drug discovery. The Bench Brief delivers concise, technical presentations directly from leading scientists. We cut the fluff to bring you core data, new applications, and validated protocols. It’s by scientists, for scientists – designed for PhD-level expertise and above. Discover breakthroughs, explore new technologies, and identify potential collaborations or investment opp...

Určitě navštivte web podcastu a podpořte jeho tvůrce: ichor.bio

Autor

ichorbio

Kategorie

Science

Web podcastu

ichor.bio

Nejnovější epizoda

4. lis 2025

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Nainstaluj zdarma Android téměř 10 mil. stažení · hodnocení 4,8 iOS už brzy

Epizody

Dr. Tommy Gambles: The Future of Multispecific Antibodies just made Bispecifics Obsolete 04.11.2025 15:14

🧬 Advancing a Modular Multispecific Antibody Platform (MATCH) for Hematologic Cancers | Dr. Tommy Gambles, Thera-T Pharmaceutics Dr. Tommy Gambles from Thera-T Pharmaceutics and the University of Utah presents groundbreaking research on the Multi-Antigen T Cell Hybridizers (MATCH) platform. This innovative technology is designed to address the two critical limitations of current T cell therapies:...

Introducing The Bench Brief 04.11.2025 1:24

Welcome to The Bench Brief, presented by ichorbio! This is your essential new resource for deep, technical insights in life sciences, cutting straight to the data that matters. Forget the fluff and marketing speak – we're all about science, by scientists, for scientists. What is The Bench Brief? We bring you concise, 10-15 minute video presentations from leading researchers, principal investigator...